Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

691 articles

Research Review

Showing 1–1 of 1 articles · Keyword: CAR-NK-derived EVs Clear keyword

Frontiers in immunology2026ReviewNon-viral Gene DeliveryDrug Delivery

1. CAR-NK cell-derived exosomes in cancer therapy: bridging cellular immunotherapy and nanomedicine

Ganjalikhani Hakemi M, Saltanatpori Z, Zhou L, Zeng X, Sun L, Liao Z

Chimeric antigen receptor-engineered natural killer (CAR-NK) cell therapy has emerged as a promising cancer treatment by combining the antigen specificity of CAR engineering with the intrinsic cytotoxicity of NK cells. Compared with CAR-T cell therapy, CAR-NK cells exhibit a lower risk of graft-versus-host disease…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.